New technology and news

Company News

Macromolecular Biopharmaceutical Research*

Macromolecular Biopharmaceutical Research*

Chengdu Tianfu International Biocity was awarded the license and recognized Changrui Biotech as the "public technology platform for carrier drug development and macromolecular biodrug research" in Biocity.

2023-02-02

Changrui Biologics - a public technical service platform for vector drug development and macromolecular biopharmaceutical research

Changrui Biologics - a public technical service platform for vector drug development and macromolecular biopharmaceutical research

On March 29, 2022, Changrui Biotechnology (Chengdu) Co., Ltd. (hereinafter referred to as "Changrui Biotechnology") was awarded the license by Chengdu Tianfu International Biocity, and recognized Changrui Biotechnology as the "public technology platform for carrier drug development and macromolecule biodrug research" in Biocity.

2023-02-02

Changrui Biotech participated in the 2022 college campus job fair

Changrui Biotech participated in the 2022 college campus job fair

On June 2, 2022, invited by the Administrative Committee of Chengdu Tianfu International Biocity, Changrui Biotech participated in the "Chengdu Tianfu International Biocity 2022 College Campus Special Job Fair" held at Southwest University for Nationalities.

2023-02-02

Changrui Biotech participated in the signing ceremony of Chengdu Tianfu International Biocity with a total investment of more than 11 billion yuan - 2022 circle building strong chain project

Changrui Biotech participated in the signing ceremony of Chengdu Tianfu International Biocity with a total investment of more than 11 billion yuan - 2022 circle building strong chain project

On June 10, 2022, Chengdu Tianfu International Biocity held a centralized signing ceremony for the "2022 Building a Circle and Strong Chain" project, and 14 projects were signed at the event site, with a total investment of more than 11 billion yuan.

2023-02-02

Changrui Biotech held the groundbreaking ceremony and the awarding ceremony of the three bases

Changrui Biotech held the groundbreaking ceremony and the awarding ceremony of the three bases

On July 18, 2022, the groundbreaking ceremony of the first phase of CDMO laboratory construction and the unveiling ceremony of the three major bases of Changrui Biotechnology (Chengdu) Co., Ltd. (hereinafter referred to as "Changrui Biotechnology") were held in Chengdu Tianfu International Biocity.

2023-02-02

The first publicity of the vehicle drug development and macromolecule biodrug R&D and pilot scale-up service platform project

The first publicity of the vehicle drug development and macromolecule biodrug R&D and pilot scale-up service platform project

Changrui Biotechnology (Chengdu) Co., Ltd. entrusted Chengdu Green Island Enterprise Management Co., Ltd. to undertake the preparation of the environmental impact report of the carrier drug development and macromolecule biodrug R&D and pilot scale-up service platform project, and according to the Measures for Public Participation in Environmental Impact Assessment (Order No. 4 of the Ministry of Ecology and Environment), the relevant information of the project is hereby published as follows:

2023-02-02

< 12 > proceed page

Macromolecular Biopharmaceutical Research*

2023-02-02

Changrui Biologics - a public technical service platform for vector drug development and macromolecular biopharmaceutical research

2023-02-02

Changrui Biotech participated in the 2022 college campus job fair

2023-02-02

Changrui Biotech participated in the signing ceremony of Chengdu Tianfu International Biocity with a total investment of more than 11 billion yuan - 2022 circle building strong chain project

2023-02-02

Changrui Biotech held the groundbreaking ceremony and the awarding ceremony of the three bases

2023-02-02

The first publicity of the vehicle drug development and macromolecule biodrug R&D and pilot scale-up service platform project

2023-02-02